KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Times Interest Earned (2019 - 2025)

Royalty Pharma (RPRX) has disclosed Times Interest Earned for 7 consecutive years, with $4.12 as the latest value for Q4 2025.

  • Quarterly Times Interest Earned fell 24.98% to $4.12 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.07 through Dec 2025, down 11.56% year-over-year, with the annual reading at $5.07 for FY2025, 11.56% down from the prior year.
  • Times Interest Earned hit $4.12 in Q4 2025 for Royalty Pharma, down from $5.37 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $19.9 in Q2 2021 to a low of -$10.28 in Q4 2022.
  • Historically, Times Interest Earned has averaged $5.78 across 5 years, with a median of $5.43 in 2025.
  • Biggest five-year swings in Times Interest Earned: tumbled 414.73% in 2022 and later surged 590.76% in 2025.
  • Year by year, Times Interest Earned stood at $3.27 in 2021, then crashed by 414.73% to -$10.28 in 2022, then skyrocketed by 226.18% to $12.97 in 2023, then tumbled by 57.61% to $5.5 in 2024, then dropped by 24.98% to $4.12 in 2025.
  • Business Quant data shows Times Interest Earned for RPRX at $4.12 in Q4 2025, $5.37 in Q3 2025, and $3.06 in Q2 2025.